• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine

Press Release: Intravacc and EpiVax team up in development of COVID-19 emerging vaccine

by Adam | Jun 2, 2020 | News

Bilthoven, The Netherlands, Providence, R.I., USA, 2 June 2020 –  Intravacc, one of the world’s leading translational research and development vaccine institutes, with an extensive track record in developing viral and bacterial vaccines, and EpiVax, a...
Press Release: Pacific GeneTech Partners With EpiVax on a Novel Vaccine Approach for ASF

Press Release: Pacific GeneTech Partners With EpiVax on a Novel Vaccine Approach for ASF

by Adam | May 1, 2020 | News

HONG KONG, May 1, 2020 (Newswire.com) – Pacific GeneTech (PGT), a biologics company that develops and commercializes next-generation vaccines for areas of high unmet or underserved needs in animal health and food safety, is collaborating with Rhode Island-based...
Providence-based EpiVax developing 2 coronavirus vaccines, needs more funding – WPRI News Channel 12 interview

Providence-based EpiVax developing 2 coronavirus vaccines, needs more funding – WPRI News Channel 12 interview

by Adam | Mar 20, 2020 | News

Providence-based EpiVax developing 2 coronavirus vaccines, needs more funding by: Sarah Doiron, Logan Wilber Posted: Mar 19, 2020 / 06:00 PM EDT / Updated: Mar 19, 2020 / 06:33 PM EDT Find the full story here. PROVIDENCE, R.I. (WPRI) ─ As the country races to stem the...
Options X for the Control of Influenza August 28th-September 1st, 2019

Options X for the Control of Influenza August 28th-September 1st, 2019

by Annie De Groot | Jun 28, 2019 | Events

The 10th Edition of Options for the Control of Influenza Wednesday, August 28th – Sunday, September 1st Suntec Convention and Exhibition Centre 1 Raffles Blvd Suntec City, Singapore 039593 Swan Tan, Graduate Research Assistant at iCubed (URI), is the recipient...
ISV 2018 Computational Vaccinology Pre-Conference Workshop October 27th, 2018 (Updated)

ISV 2018 Computational Vaccinology Pre-Conference Workshop October 27th, 2018 (Updated)

by Annie De Groot | Oct 10, 2018 | Events

  ISV 2018 Computational Vaccinology Pre-Conference Workshop Saturday, October 27th 9:00AM-4:00PM UPDATE: Here are commemorative photos from our event. Thank you to all the speakers and participants for making the 2018 seminar a success. See you next year! Join...
Next Entries »

Recent Posts

  • Optimize Your Immunogenicity Strategy with Trusted Expert Advice 
  • Tregs, Epitopes, and the Future of Immune Tolerance
  • The Platinum Vaccine & Change is Good!
  • EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
  • Smarter Tools, Safer Therapies: Supporting the FDA’s Roadmap with in silico Immunogenicity Assessment

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.